Clinical Trials Browser

Recruiting × Pancreatic Adenocarcinoma × Taxes × Clear all

NCT05624918 2025-07-31

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma